POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)

UCB

Status and phase: Completed; Phase 4

Conditions: Seasonal Allergic Rhinitis

Treatments: Drug: Levocetirizine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00160537

POPULAR

EudraCT 2004-002971-18

A00391

Details and patient eligibility

About

Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical history of SAR known and treated since 2 years.
• Positive skin prick test (wheal > 3 mm larger than the diluent control) or RAST (≥3.5 IU/ml) to grass pollen (less than 1 year).
• Minimum mean T5SS of 8 during the baseline period.

Exclusion criteria

• Have an associated asthma requiring a daily treatment other than β2 short acting agonist prn
• Have atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids and any other disease requiring the administration of oral or topical corticosteroids